627 related articles for article (PubMed ID: 20300169)
1. Capillary electrophoresis mass spectrometry-based saliva metabolomics identified oral, breast and pancreatic cancer-specific profiles.
Sugimoto M; Wong DT; Hirayama A; Soga T; Tomita M
Metabolomics; 2010 Mar; 6(1):78-95. PubMed ID: 20300169
[TBL] [Abstract][Full Text] [Related]
2. Identification of salivary metabolomic biomarkers for oral cancer screening.
Ishikawa S; Sugimoto M; Kitabatake K; Sugano A; Nakamura M; Kaneko M; Ota S; Hiwatari K; Enomoto A; Soga T; Tomita M; Iino M
Sci Rep; 2016 Aug; 6():31520. PubMed ID: 27539254
[TBL] [Abstract][Full Text] [Related]
3. Salivary metabolomics with alternative decision tree-based machine learning methods for breast cancer discrimination.
Murata T; Yanagisawa T; Kurihara T; Kaneko M; Ota S; Enomoto A; Tomita M; Sugimoto M; Sunamura M; Hayashida T; Kitagawa Y; Jinno H
Breast Cancer Res Treat; 2019 Oct; 177(3):591-601. PubMed ID: 31286302
[TBL] [Abstract][Full Text] [Related]
4. Metabolomics Analysis of Blood, Urine, and Saliva Samples Based on Capillary Electrophoresis-Mass Spectrometry.
Sugimoto M; Aizawa Y
Methods Mol Biol; 2023; 2571():83-94. PubMed ID: 36152152
[TBL] [Abstract][Full Text] [Related]
5. Quantification of Salivary Charged Metabolites using Capillary Electrophoresis Time-of-flight-mass Spectrometry.
Sugimoto M; Ota S; Kaneko M; Enomoto A; Soga T
Bio Protoc; 2020 Oct; 10(20):e3797. PubMed ID: 33659451
[TBL] [Abstract][Full Text] [Related]
6. Salivary metabolite signatures of oral cancer and leukoplakia.
Wei J; Xie G; Zhou Z; Shi P; Qiu Y; Zheng X; Chen T; Su M; Zhao A; Jia W
Int J Cancer; 2011 Nov; 129(9):2207-17. PubMed ID: 21190195
[TBL] [Abstract][Full Text] [Related]
7. Prediction of Periodontal Inflammation via Metabolic Profiling of Saliva.
Kuboniwa M; Sakanaka A; Hashino E; Bamba T; Fukusaki E; Amano A
J Dent Res; 2016 Nov; 95(12):1381-1386. PubMed ID: 27470067
[TBL] [Abstract][Full Text] [Related]
8. Serum Metabolomic Profiles for Human Pancreatic Cancer Discrimination.
Itoi T; Sugimoto M; Umeda J; Sofuni A; Tsuchiya T; Tsuji S; Tanaka R; Tonozuka R; Honjo M; Moriyasu F; Kasuya K; Nagakawa Y; Abe Y; Takano K; Kawachi S; Shimazu M; Soga T; Tomita M; Sunamura M
Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28375170
[TBL] [Abstract][Full Text] [Related]
9. Effect of timing of collection of salivary metabolomic biomarkers on oral cancer detection.
Ishikawa S; Sugimoto M; Kitabatake K; Tu M; Sugano A; Yamamori I; Iba A; Yusa K; Kaneko M; Ota S; Hiwatari K; Enomoto A; Masaru T; Iino M
Amino Acids; 2017 Apr; 49(4):761-770. PubMed ID: 28101653
[TBL] [Abstract][Full Text] [Related]
10. Salivary metabolomics with machine learning for colorectal cancer detection.
Kuwabara H; Katsumata K; Iwabuchi A; Udo R; Tago T; Kasahara K; Mazaki J; Enomoto M; Ishizaki T; Soya R; Kaneko M; Ota S; Enomoto A; Soga T; Tomita M; Sunamura M; Tsuchida A; Sugimoto M; Nagakawa Y
Cancer Sci; 2022 Sep; 113(9):3234-3243. PubMed ID: 35754317
[TBL] [Abstract][Full Text] [Related]
11. Identification of salivary metabolites for oral squamous cell carcinoma and oral epithelial dysplasia screening from persistent suspicious oral mucosal lesions.
Ishikawa S; Wong DTW; Sugimoto M; Gleber-Netto FO; Li F; Tu M; Zhang Y; Akin D; Iino M
Clin Oral Investig; 2019 Sep; 23(9):3557-3563. PubMed ID: 30539290
[TBL] [Abstract][Full Text] [Related]
12. Metabolomic analysis of the saliva of Japanese patients with oral squamous cell carcinoma.
Ohshima M; Sugahara K; Kasahara K; Katakura A
Oncol Rep; 2017 May; 37(5):2727-2734. PubMed ID: 28393236
[TBL] [Abstract][Full Text] [Related]
13. Urinary charged metabolite profiling of colorectal cancer using capillary electrophoresis-mass spectrometry.
Udo R; Katsumata K; Kuwabara H; Enomoto M; Ishizaki T; Sunamura M; Nagakawa Y; Soya R; Sugimoto M; Tsuchida A
Sci Rep; 2020 Dec; 10(1):21057. PubMed ID: 33273632
[TBL] [Abstract][Full Text] [Related]
14. Discrimination of oral squamous cell carcinoma from oral lichen planus by salivary metabolomics.
Ishikawa S; Sugimoto M; Edamatsu K; Sugano A; Kitabatake K; Iino M
Oral Dis; 2020 Jan; 26(1):35-42. PubMed ID: 31602722
[TBL] [Abstract][Full Text] [Related]
15. Salivary metabolite signatures of oral cancer and leukoplakia through gas chromatography-mass spectrometry.
Tantray S; Sharma S; Prabhat K; Nasrullah N; Gupta M
J Oral Maxillofac Pathol; 2022; 26(1):31-37. PubMed ID: 35571322
[TBL] [Abstract][Full Text] [Related]
16. Saliva metabolomics opens door to biomarker discovery, disease diagnosis, and treatment.
Zhang A; Sun H; Wang X
Appl Biochem Biotechnol; 2012 Nov; 168(6):1718-27. PubMed ID: 22971835
[TBL] [Abstract][Full Text] [Related]
17. The Saliva Metabolome in Association to Oral Health Status.
Liebsch C; Pitchika V; Pink C; Samietz S; Kastenmüller G; Artati A; Suhre K; Adamski J; Nauck M; Völzke H; Friedrich N; Kocher T; Holtfreter B; Pietzner M
J Dent Res; 2019 Jun; 98(6):642-651. PubMed ID: 31026179
[TBL] [Abstract][Full Text] [Related]
18. Metabolic system alterations in pancreatic cancer patient serum: potential for early detection.
Ritchie SA; Akita H; Takemasa I; Eguchi H; Pastural E; Nagano H; Monden M; Doki Y; Mori M; Jin W; Sajobi TT; Jayasinghe D; Chitou B; Yamazaki Y; White T; Goodenowe DB
BMC Cancer; 2013 Sep; 13():416. PubMed ID: 24024929
[TBL] [Abstract][Full Text] [Related]
19. Salivary metabolite levels in perinatally HIV-infected youth with periodontal disease.
Schulte F; King OD; Paster BJ; Moscicki AB; Yao TJ; Van Dyke RB; Shiboski C; Ryder M; Seage G; Hardt M;
Metabolomics; 2020 Sep; 16(9):98. PubMed ID: 32915320
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
